Package Leaflet: Information for the User
Efedrina Level 50 mg Tablets
Efedrine Hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Efedrine hydrochloride belongs to a group of medicines called alpha and beta adrenergic receptor agonists, which act as bronchodilators (widen the airways in the lungs).
This medicine is used to prevent and treat bronchospasm (narrowing of the airways in the lungs) associated with acute attacks of bronchial asthma, spasmodic bronchitis or pulmonary emphysema.
Do not take Efedrina Level
1
Warnings and precautions
Consult your doctor or pharmacist before starting to take Efedrina Level.
This medicine should be administered with caution in patients:
Children and adolescents
They may be more sensitive to the adverse effects, including stimulation of the central nervous system (CNS).
Taking Efedrina Level with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, if it is one of the following medicines, as it may be necessary to modify the dose and/or have additional monitoring by the doctor:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Efedrina Level should not be used during the third trimester of pregnancy unless the woman's situation requires treatment with efedrine hydrochloride and there are no safer therapeutic alternatives.
Breastfeeding
Efedrine hydrochloride is excreted in breast milk. A decision must be made whether to discontinue breastfeeding or discontinue treatment, considering the benefit of breastfeeding for the child and the benefit of treatment for the mother.
Driving and using machines
2
The influence of Efedrina Level on the ability to drive and use machines is moderate.
In case of adverse effects, it is recommended not to drive or use hazardous machinery.
Use in athletes
Athletes are informed that this medicine contains a component that may result in a positive doping test.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.
The recommended dose in adults is 1 tablet (50 mg of efedrine hydrochloride) 2 to 3 times a day. Elderly patients may need a dose adjustment.
Use in children and adolescents
The safety and efficacy of this medicine in children and adolescents have not been established.
If you take more Efedrina Level than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount used.
In case of severe poisoning, the stomach should be immediately emptied by aspiration and washing.
Insomnia and other stimulating effects of efedrine on the central nervous system can be counteracted by the administration of hypnotics.
To control excitement, sedatives such as chlorpromazine can be administered at a dose of 50 or 100 mg intramuscularly or a barbiturate.
To control tachycardia, propranolol can be administered intravenously slowly or beta-adrenergic blockers (e.g., acebutolol, atenolol, metoprolol) in asthmatic patients.
The elimination of efedrine can be facilitated by acidifying the urine with ammonium chloride.
If you forget to take Efedrina Level
Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
3
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep below 30 ºC.
Keep this medicine out of the sight and reach of children.
Do not use Efedrina Level after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Efedrina Level
Appearance and packaging
Efedrina Level is presented in PVC-aluminum blisters. Each pack contains 24 tablets.
Marketing authorization holder
LABORATORIOS ERN, S.A.
Perú, 228 - 08020 Barcelona. Spain
Manufacturer
LABORATORIOS ERN, S.A.
Gorgs Lladó, 188 – 08210 Barberá del Vallés, Barcelona. Spain
Date of last revision of this leaflet: May 2020
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
4